Praram 9 Hospital Public Co Limited

As of June 30, 2026, Praram 9 Hospital Public Co Limited carries a market capitalization of 13.92B, placing it among publicly traded companies globally. Its enterprise value stands at 11.20B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Praram 9 Hospital Public Co Limited's next confirmed earnings release is scheduled for November 6, 2026.

As of June 30, 2026, Praram 9 Hospital Public Co Limited has 786.30M shares outstanding.

As of June 30, 2026, Praram 9 Hospital Public Co Limited trades at a trailing price-to-earnings ratio of 17.20. The price-to-sales ratio is 2.60, and the price-to-book ratio stands at 2.32.

As of June 30, 2026, Praram 9 Hospital Public Co Limited trades at an EV/EBITDA multiple of 8.71 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 2.09 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 11.79 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. Praram 9 Hospital Public Co Limited trades at an EV/FCF ratio of 40.77, comparing the total takeover cost of the business to the cash it actually generates for all capital providers. These enterprise value multiples are built on an enterprise value of 11.20B versus a market cap of 13.92B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Praram 9 Hospital Public Co Limited maintains a current ratio of 3.89, meaning it holds 3.9x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 0.23, indicating conservative leverage, while an interest coverage ratio of 1,156.17 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Praram 9 Hospital Public Co Limited posted a return on equity (ROE) of 13.91, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 13.34 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 11.71, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 13.90, useful for judging operating efficiency across full business cycles. The company generates approximately 2.66M in revenue per employee across its workforce of 2,011.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 49.63 indicates how many times Praram 9 Hospital Public Co Limited sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Praram 9 Hospital Public Co Limited recorded 180.12M in income tax expense. That works out to an effective tax rate of 18.21, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 989.19M, leaving 809.07M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 22, 2026, Praram 9 Hospital Public Co Limited's stock has declined approximately 17.39% over the past 52 weeks. The 50-day moving average sits at 18.95, while the 200-day moving average is 17.92.

Over the twelve months ended June 30, 2026, Praram 9 Hospital Public Co Limited generated 5.36B in revenue and converted that into 809.07M in net income, yielding earnings per share of 1.03. EBITDA reached 1.29B, while operating income came in at 933.34M.

As of June 30, 2026, Praram 9 Hospital Public Co Limited holds 2.73B in cash and equivalents against 13.88M in total debt, resulting in a net debt position of -1.02B. Total book value stands at 6.01B, with working capital of 2.54B providing operational flexibility.

Praram 9 Hospital Public Co Limited produced 859.09M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -585.21M in capital expenditures, free cash flow totaled 273.88M - equivalent to 0.35 per share.

Over the twelve months ended June 30, 2026, Praram 9 Hospital Public Co Limited posted a gross margin of 36.06, reflecting its pricing power and cost economics. The operating margin of 17.43 and net profit margin of 15.11 provide insight into operational efficiency.

Over the twelve months ended June 30, 2026, Praram 9 Hospital Public Co Limited paid dividends of 0.50 per share. The dividend payout ratio of 48.32 indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield stands at 1.97, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 2.88, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Praram 9 Hospital Public Co Limited shareholders.

As of June 30, 2026, Praram 9 Hospital Public Co Limited has an Altman Z-Score of 9.49, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.